CervoMed Inc. (CRVO) Financials

CRVO Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 15.1 million 4.5 million
Dec. 31, 2025 23.4 million 5.2 million
Sept. 30, 2025 30.6 million 4.6 million
June 30, 2025 38.1 million 4.6 million

CRVO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -8.0 million 349196
Dec. 31, 2025 -6.6 million 298735
Sept. 30, 2025 -6.5 million 291717
June 30, 2025 -6.5 million 497015

CRVO Net Income

No data available :(

CRVO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 12.9 million - -
Dec. 31, 2025 20.9 million - -
Sept. 30, 2025 27.3 million - -
June 30, 2025 33.5 million - -

CRVO Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 9.3 million
Dec. 31, 2025 9.3 million
Sept. 30, 2025 9.3 million
June 30, 2025 9.0 million

CRVO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 5.1 million 3.0 million -
Dec. 31, 2025 - 5.8 million 2.5 million -
Sept. 30, 2025 - 6.0 million 2.3 million -
June 30, 2025 5 5.1 million 3.3 million -

CRVO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - -
Dec. 31, 2025 8726 -
Sept. 30, 2025 322569 -
June 30, 2025 1.8 million -

CRVO

Price: $4.24

52 week price:
2.25
13.13

Earnings Per Share: -3.28 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 27.5 million

Links: